English
Spanish
FDA Approves Pfizer’s COVID-19 Vaccine
The FDA approved the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. The vaccine will now be marketed as Comirnaty.
Read More ›
New Mexico Mask Mandate Re-Instated
The most recent New Mexico Public Health Order states that, as of August 20, 2021 everyone in New Mexico over the age of 2, regardless of vaccination status, is required to wear a mask or cloth face covering when in public except when drinking, eating, or under medical instruction.
Read More ›
COVID-19 Vaccines for Immunocompromised People
CDC now recommends that people whose immune systems are compromised moderately to severely should receive an additional dose of mRNA COVID-19 vaccine after the initial 2 doses. Widespread vaccination is a critical tool to help stop the pandemic.
Read More ›
Vaccine Incentive Program Returns
Beginning Monday, August 2, 2021, and until August 31, 2021, all New Mexicans will be eligible for a $100 incentive for getting a dose of COVID-19 vaccine during this time period.
Read More ›
Resources & Guidance on Long COVID as a Disability
In light of the rise of long COVID as a persistent and significant health issue, the Office for Civil Rights of the Department of Health and Human Services and the Civil Rights Division of the Department of Justice have joined together to provide guidance on “long COVID” as a disability under the ADA, Section 504, and Section 1557.
Read More ›
Updated Mask Guidance
The CDC has updated their mask guidance for fully vaccinated people given new evidence on the Delta variant currently circulating in the United States. To maximize protection from the Delta variant and prevent possibly spreading it to others, wear a mask indoors in public if you are in an area of substantial or high transmission.
Read More ›